1.96 USD
↘ 0.01 (0.51%)AT CLOSE (03:59 PM EST)
Pacific Biosciences of California, Inc. (PACB) is currently trading at $1.96. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (213.8%) and a bullish Golden Cross on the moving averages. On the valuation front, PACB trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.